Cresco Labs Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Charlie Bachtell

Algemeen directeur

US$450.0k

Totale compensatie

Percentage CEO-salaris	100.0%
Dienstverband CEO	6yrs
Eigendom CEO	0.6%
Management gemiddelde ambtstermijn	5.1yrs
Gemiddelde ambtstermijn bestuur	6yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Charlie Bachtell's beloning veranderd ten opzichte van Cresco Labs's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$67m
Jun 30 2024	n/a	n/a	-US$172m
Mar 31 2024	n/a	n/a	-US$155m
Dec 31 2023	US$450k	US$450k	-US$176m
Sep 30 2023	n/a	n/a	-US$339m
Jun 30 2023	n/a	n/a	-US$234m
Mar 31 2023	n/a	n/a	-US$211m
Dec 31 2022	US$1m	US$450k	-US$212m
Sep 30 2022	n/a	n/a	-US$65m
Jun 30 2022	n/a	n/a	-US$326m
Mar 31 2022	n/a	n/a	-US$318m
Dec 31 2021	US$1m	US$450k	-US$320m
Sep 30 2021	n/a	n/a	-US$360m
Jun 30 2021	n/a	n/a	-US$73m
Mar 31 2021	n/a	n/a	-US$105m
Dec 31 2020	US$538k	US$450k	-US$102m
Sep 30 2020	n/a	n/a	-US$76m
Jun 30 2020	n/a	n/a	-US$98m
Mar 31 2020	n/a	n/a	-US$64m
Dec 31 2019	US$676k	US$350k	-US$43m
Sep 30 2019	n/a	n/a	-US$20m
Jun 30 2019	n/a	n/a	-US$14m
Mar 31 2019	n/a	n/a	-US$12m
Dec 31 2018	US$924k	US$350k	-US$2m
Sep 30 2018	n/a	n/a	US$460k
Jun 30 2018	n/a	n/a	US$1m
Mar 31 2018	n/a	n/a	US$957k
Dec 31 2017	US$188k	US$188k	-US$3m

Compensatie versus markt: De totale vergoeding ($USD 450.00K ) Charlie } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 2.14M ).

Compensatie versus inkomsten: De vergoeding van Charlie is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Charlie Bachtell (45 yo)

6yrs

Tenure

US$450,000

Compensatie

Mr. Charles Bachtell, also known as Charlie, serves as Co-Founder and Chief Executive Officer at Cresco Labs Inc. (formerly known as Cresco Labs, LLC) and has been its Director since November 2018. Mr. Bac...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Charles Bachtell	Co-Founder	no data	US$450.00k	0.58% $ 2.8m
Gregory Butler	President & Chief Transformation Officer	less than a year	US$533.50k	0.024% $ 111.9k
Robert Sampson	Co-Founder & Independent Director	no data	US$72.50k	0.12% $ 574.3k
Sharon Schuler	Chief Financial Officer	less than a year	geen gegevens	geen gegevens
Ty Gent	Chief Operating Officer	3.8yrs	geen gegevens	geen gegevens
Zach Marburger	Chief Information Officer	no data	geen gegevens	0.036% $ 169.1k
John Schetz	General Counsel	6.4yrs	geen gegevens	0.027% $ 129.7k
Jason Erkes	Chief Communications Officer	6yrs	geen gegevens	0.081% $ 384.5k
Angie Demchenko	Chief People Officer	5.3yrs	geen gegevens	0.018% $ 86.0k
Joseph Ales	Senior VP of Operations	no data	geen gegevens	geen gegevens
Todd West	Executive Vice President of Operations	6.8yrs	geen gegevens	geen gegevens
Drew Duval	Senior Vice President of Cultivation	4.8yrs	geen gegevens	geen gegevens

5.1yrs

Gemiddelde duur

47yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CRLB.F is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Charles Bachtell	Co-Founder	6yrs	US$450.00k	0.58% $ 2.8m
Robert Sampson	Co-Founder & Independent Director	6yrs	US$72.50k	0.12% $ 574.3k
Marc Lustig	Independent Director	4.8yrs	US$65.00k	0.012% $ 55.8k
Gerald Corcoran	Independent Director	6yrs	US$87.50k	0.11% $ 532.5k
Thomas J. Manning	Chairman of the Board	6yrs	US$92.81k	0.067% $ 319.9k
Michele Roberts	Independent Director	4.4yrs	US$116.00k	0.0057% $ 27.4k
Randy Podolsky	Independent Director	6yrs	US$80.00k	0.021% $ 101.3k

6.0yrs

Gemiddelde duur

67yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CRLB.F wordt beschouwd als ervaren (gemiddelde ambtstermijn 6 jaar).

Cresco Labs Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Cresco Labs Inc. Announces Resignation of Tarik Brooks as Board of Directors

Cresco Labs Inc. Announces CFO Changes

Cresco Labs Inc., Annual General Meeting, Jun 10, 2024

Cresco Labs Inc. Promotes Greg Butler to the Position of President

Cresco Labs Inc. Announces Resignation of Sidney Dillard from the Board of Director

Cresco Labs Inc., Annual General Meeting, Jun 30, 2022

Recent updates

Cresco Labs Inc. to Report Q3, 2024 Results on Nov 08, 2024

Cresco Labs Inc. Announces Resignation of Tarik Brooks as Board of Directors

Cresco Labs Inc. Announces CFO Changes

Cresco Labs Inc. to Report Q2, 2024 Results on Aug 08, 2024

Cresco Labs Inc. (CNSX:CL) acquired Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC for $9.8 million.

Cresco Labs Inc. to Report Q1, 2024 Results on May 15, 2024

Cresco Labs Inc., Annual General Meeting, Jun 10, 2024

Cresco Labs Inc. to Report Q4, 2023 Results on Mar 13, 2024

Cresco Labs Inc. Promotes Greg Butler to the Position of President

Cresco Labs Inc. to Report Q3, 2023 Results on Nov 15, 2023

Cresco Labs Inc. completed the acquisition of Sole Licensed Arizona Operation of Cresco Labs Inc.

Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023

Cresco Labs Inc. to Report Q2, 2023 Results on Aug 16, 2023

Cresco Labs Inc. to Report Q1, 2023 Results on May 24, 2023

Combs Enterprises signed a definitive agreements to acquire Certain New York, Illinois, and Massachusetts assets of Cresco Labs Inc. and Columbia Care Inc. for approximately $190 million.

Cresco Labs Inc. to Report Q3, 2022 Results on Nov 15, 2022

Cresco Labs Inc. Announces Resignation of Sidney Dillard from the Board of Director

Aventine Property Group, Inc. acquired Cresco Labs Facility in Brookville, PA for $45 million

Cresco Labs Inc. to Report Q2, 2022 Results on Aug 17, 2022

Cresco Labs Inc. to Report Q1, 2022 Results on May 18, 2022

Cresco Labs Inc., Annual General Meeting, Jun 30, 2022

Cresco Labs Inc. Launches Floracal Farms Brand to Illinois

Cresco Labs Announces Launch of Khalifa Kush Products at Cookies Dispensaries Throughout California

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Laurel Harvest Labs, LLC for $80 million.

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Bay, LLC.

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Bay, LLC for $90 million.

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Cultivate Holdings, LLC.

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Blair Wellness, LLC.

Cresco Labs Inc. Provides Earnings Guidance for the Year 2021

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Cultivate Holdings, LLC for $158 million.

IM Cannabis Corp. (CNSX:IMCC) completed the acquisition of Trichome Financial Corp. (CNSX:TFC) from Cresco Labs Inc., Opaskawayak Cree Nation and others.

Cresco Labs Inc. to Report Q4, 2020 Results on Mar 25, 2021

Cresco Labs Inc. (CNSX:CL) acquired Four dispensaries of Verdant Creations.

Cresco Labs Signs Exclusive Distribution Agreement with California Cannabis Producer, Emerald Family Farms

Cresco Labs Appoints Ty Gent as the New Chief Operating Officer

Cresco Labs Expands High Supply Brand Portfolio to Include 1.0 g and 0.5 mg Live Cartridges Available in California and Illinois

Cresco Labs Inc. has completed a Follow-on Equity Offering in the amount of CAD 158.047776 million.

Cresco Labs Announces Executive Changes

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire all of the issued and outstanding shares of Bluma Wellness Inc. (CNSX:BWEL.U) for approximately $180 million.

Cresco Labs Debuts Deliciously DosedTM Chocolates from its Mindy's Chef Led Artisanal Edibles Brand for the Illinois Recreational Cannabis Market

Cresco Labs Launches Eighth Cannabis Brand, Wonder Wellness Co

Cresco Labs Launches 1.0 g Liquid Live Resin Vape Offering in Illinois and California

Cresco Labs Launches Remedi Cannabis Brand into New York

Cresco Labs Inc. to Report Q3, 2020 Results on Nov 18, 2020

Cresco Labs Bolsters Leadership Team with Three Senior Promotions

Innovative Industrial Properties, Inc. (NYSE:IIPR) completed the acquisition of two properties in Ohio and Michigan from Cresco Labs Inc. (CNSX:CL).

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd